HTSUY
Price
$6.65
Change
-$0.15 (-2.21%)
Updated
Nov 12 closing price
Capitalization
1.91B
Intraday BUY SELL Signals
ORXOY
Price
$2.90
Change
+$0.15 (+5.45%)
Updated
Nov 10 closing price
Capitalization
102.64M
Intraday BUY SELL Signals
Interact to see
Advertisement

HTSUY vs ORXOY

Header iconHTSUY vs ORXOY Comparison
Open Charts HTSUY vs ORXOYBanner chart's image
Hisamitsu Pharmaceutical
Price$6.65
Change-$0.15 (-2.21%)
Volume$300
Capitalization1.91B
Orexo AB
Price$2.90
Change+$0.15 (+5.45%)
Volume$950
Capitalization102.64M
HTSUY vs ORXOY Comparison Chart in %
HTSUY
Daily Signal:
Gain/Loss:
ORXOY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HTSUY vs. ORXOY commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HTSUY is a Hold and ORXOY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (HTSUY: $6.65 vs. ORXOY: $2.90)
Brand notoriety: HTSUY and ORXOY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HTSUY: 277% vs. ORXOY: 341%
Market capitalization -- HTSUY: $1.91B vs. ORXOY: $102.64M
HTSUY [@Pharmaceuticals: Generic] is valued at $1.91B. ORXOY’s [@Pharmaceuticals: Generic] market capitalization is $102.64M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HTSUY’s FA Score shows that 2 FA rating(s) are green whileORXOY’s FA Score has 0 green FA rating(s).

  • HTSUY’s FA Score: 2 green, 3 red.
  • ORXOY’s FA Score: 0 green, 5 red.
According to our system of comparison, HTSUY is a better buy in the long-term than ORXOY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HTSUY’s TA Score shows that 1 TA indicator(s) are bullish while ORXOY’s TA Score has 3 bullish TA indicator(s).

  • HTSUY’s TA Score: 1 bullish, 3 bearish.
  • ORXOY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, HTSUY is a better buy in the short-term than ORXOY.

Price Growth

HTSUY (@Pharmaceuticals: Generic) experienced а -2.13% price change this week, while ORXOY (@Pharmaceuticals: Generic) price change was -3.01% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.60%. For the same industry, the average monthly price growth was -4.48%, and the average quarterly price growth was +31.78%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.60% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HTSUY($1.92B) has a higher market cap than ORXOY($103M). ORXOY YTD gains are higher at: 53.846 vs. HTSUY (-6.140). HTSUY has higher annual earnings (EBITDA): 32.5B vs. ORXOY (33.5M). HTSUY has more cash in the bank: 113B vs. ORXOY (121M). ORXOY has less debt than HTSUY: ORXOY (496M) vs HTSUY (2.38B). HTSUY has higher revenues than ORXOY: HTSUY (155B) vs ORXOY (561M).
HTSUYORXOYHTSUY / ORXOY
Capitalization1.92B103M1,859%
EBITDA32.5B33.5M97,015%
Gain YTD-6.14053.846-11%
P/E Ratio15.21N/A-
Revenue155B561M27,629%
Total Cash113B121M93,388%
Total Debt2.38B496M479%
FUNDAMENTALS RATINGS
ORXOY: Fundamental Ratings
ORXOY
OUTLOOK RATING
1..100
92
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HTSUYORXOY
RSI
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 2 days ago
50%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
37%
Momentum
ODDS (%)
Bearish Trend 2 days ago
7%
Bearish Trend 2 days ago
43%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
3%
Bearish Trend 2 days ago
40%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
10%
Bearish Trend 2 days ago
33%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
44%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
38%
View a ticker or compare two or three
Interact to see
Advertisement
HTSUY
Daily Signal:
Gain/Loss:
ORXOY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIDZX38.09N/A
N/A
Fidelity Advisor Intl Cap App Z
MNMWX15.26-0.09
-0.59%
Manning & Napier Pro-Blend Mod Trm W
USISX19.33-0.15
-0.77%
Victory Income Stock
CRFIX12.57-0.17
-1.33%
Calvert Focused Value I
GSSSX33.59-0.55
-1.61%
Goldman Sachs Small Cap Value Svc

HTSUY and

Correlation & Price change

A.I.dvisor tells us that HTSUY and TKNO have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HTSUY and TKNO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HTSUY
1D Price
Change %
HTSUY100%
N/A
TKNO - HTSUY
4%
Poorly correlated
-0.67%
BFRI - HTSUY
4%
Poorly correlated
-8.59%
ORXOY - HTSUY
0%
Poorly correlated
N/A
HNSPF - HTSUY
0%
Poorly correlated
N/A
SWGHF - HTSUY
-1%
Poorly correlated
N/A
More

ORXOY and

Correlation & Price change

A.I.dvisor tells us that ORXOY and APNHF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORXOY and APNHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORXOY
1D Price
Change %
ORXOY100%
N/A
APNHF - ORXOY
28%
Poorly correlated
N/A
TKNO - ORXOY
8%
Poorly correlated
-0.67%
SEHCF - ORXOY
5%
Poorly correlated
N/A
GLASF - ORXOY
4%
Poorly correlated
-6.66%
HTSUY - ORXOY
0%
Poorly correlated
N/A
More